Related Experiment Video
Updated: Jan 23, 2026

Evaluating Cell Death Signaling by Immunofluorescence in a Rat Model of Ischemic Stroke
Published on: January 3, 2025
S100a8/a9 Signaling Causes Mitochondrial Dysfunction and Cardiomyocyte Death in Response to Ischemic/Reperfusion
Yulin Li1, Boya Chen1, Xinying Yang1
1Beijing Anzhen Hospital of Capital Medical University and Beijing Institute of Heart Lung and Blood Vessel Diseases, China (Y. Li, B.C., Z.Y., C.Z., Y.J., P.L., Y. Liu, Z.L., B.Q., J.D.).
Background:
Myocardial ischemia-reperfusion (MI/R) injury is a significant clinical problem without effective therapy. Unbiased omics approaches may reveal key MI/R mediators to initiate MI/R injury.
Methods:
We used a dynamic transcriptome analysis of mouse heart exposed to various MI/R periods to identify S100a8/a9 as an early mediator. Using loss/gain-of-function approaches to understand the role of S100a8/a9 in MI/R injury, we explored the mechanisms through transcriptome and functional experiment. Dynamic serum S100a8/a9 levels were measured in patients with acute myocardial infarction before and after percutaneous coronary intervention. Patients were prospectively followed for the occurrence of major adverse cardiovascular events.
Results:
S100a8/a9 was identified as the most significantly upregulated gene during the early reperfusion stage. Knockout of S100a9 markedly decreased cardiomyocyte death and improved heart function, whereas hematopoietic overexpression of S100a9 exacerbated MI/R injury. Transcriptome/functional studies revealed that S100a8/a9 caused mitochondrial respiratory dysfunction in cardiomyocytes. Mechanistically, S100a8/a9 downregulated NDUF gene expression with subsequent mitochondrial complex I inhibition via Toll-like receptor 4/Erk-mediated Pparg coactivator 1 alpha/nuclear respiratory factor 1 signaling suppression. Administration of S100a9 neutralizing antibody significantly reduced MI/R injury and improved cardiac function. Finally, we demonstrated that serum S100a8/a9 levels were significantly increased 1 day after percutaneous coronary intervention in patients with acute myocardial infarction, and elevated S100a8/a9 levels were associated with the incidence of major adverse cardiovascular events.
Conclusions:
Our study identified S100a8/a9 as a master regulator causing cardiomyocyte death in the early stage of MI/R injury via the suppression of mitochondrial function. Targeting S100a8/a9-intiated signaling may represent a novel therapeutic intervention against MI/R injury.
Clinical Trial Registration:
URL: https://www.clinicaltrials.gov. Unique identifier: NCT03752515.
Insights
Myocardial ischemia-reperfusion (MI/R) injury is a critical condition. This study identifies S100a8/a9 as a key mediator of MI/R injury, offering a potential therapeutic target for heart attack recovery.
Area of Science:
- Cardiovascular Research
- Molecular Medicine
- Proteomics and Genomics
Background:
- Myocardial ischemia-reperfusion (MI/R) injury poses a significant clinical challenge with limited therapeutic options.
- Unbiased omics approaches are crucial for identifying novel mediators of MI/R injury.
Purpose of the Study:
- To identify early mediators of MI/R injury using dynamic transcriptome analysis.
- To elucidate the role and mechanism of S100a8/a9 in MI/R injury.
- To investigate the clinical relevance of S100a8/a9 in patients with acute myocardial infarction.
Main Methods:
- Dynamic transcriptome analysis of mouse hearts subjected to MI/R.
- Loss-of-function and gain-of-function studies of S100a8/a9.
- Measurement of serum S100a8/a9 levels in MI patients post-PCI and follow-up for major adverse cardiovascular events.
Main Results:
- S100a8/a9 was identified as the most upregulated gene during early reperfusion.
- S100a9 knockout improved cardiac function, while overexpression worsened injury.
- S100a8/a9 induced mitochondrial dysfunction by inhibiting Complex I via TLR4/ERK/PPARGC1A/NRF1 signaling.
- S100a9 neutralizing antibody treatment reduced MI/R injury.
- Elevated serum S100a8/a9 levels post-PCI in MI patients correlated with adverse cardiovascular events.
Conclusions:
- S100a8/a9 is a critical regulator of cardiomyocyte death in early MI/R injury by suppressing mitochondrial function.
- Targeting S100a8/a9-mediated signaling presents a promising novel therapeutic strategy for MI/R injury.
Related Concept Videos
Diversity in Cell Signaling Responses
Graded and Abrupt Responses
Some signaling systems generate...
Animal Mitochondrial Genetics
Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes
Export of Mitochondrial and Chloroplast Genes
What is Cell Signaling?
Paracrine Signaling

